Compare Stocks → Trump’s Gift Could Unleash $51 Billion in New Wealth (From Wealthpin Pro) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDigital Media StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison CVE:BMKNASDAQ:KLDONASDAQ:LXRXNASDAQ:PLSE Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBMKMacDonald Mines ExplorationC$0.04C$0.04C$0.03▼C$0.09C$1.33M0.4667,512 shs73,000 shsKLDOKaleido Biosciences$0.00$0.00▼$0.25$6.39M-0.063,408 shs2,784 shsLXRXLexicon Pharmaceuticals$1.75+2.9%$1.83$0.92▼$3.73$418.60M1.381.97 million shs2.34 million shsPLSEPulse Biosciences$13.59+17.7%$8.45$3.78▼$13.88$637.85M1.75257,757 shs573,161 shs7 Energy Stocks to Buy and Hold ForeverDo you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBMKMacDonald Mines Exploration0.00%0.00%0.00%-41.67%-46.15%KLDOKaleido Biosciences0.00%0.00%0.00%0.00%-50.00%LXRXLexicon Pharmaceuticals+2.94%+8.02%+0.57%-22.22%-36.25%PLSEPulse Biosciences+17.66%+19.53%+73.79%+48.20%+112.34%The Worst is Yet to Come… (Ad)Millions of Unsuspecting Americans Could be Wiped Out… Yet those who watch this bombshell exposé and prepare before it’s too late could have the chance to protect their financial future and grow their wealth significantly.Click here to stream this controversial exposé now.MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBMKMacDonald Mines ExplorationN/AN/AN/AN/AN/AN/AN/AN/AKLDOKaleido BiosciencesN/AN/AN/AN/AN/AN/AN/AN/ALXRXLexicon Pharmaceuticals1.531 of 5 stars3.32.00.00.01.91.70.6PLSEPulse Biosciences0.9781 of 5 stars0.00.00.04.22.65.00.0Analyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBMKMacDonald Mines ExplorationN/AN/AN/AN/AKLDOKaleido BiosciencesN/AN/AN/AN/ALXRXLexicon Pharmaceuticals2.67Moderate Buy$5.00185.71% UpsidePLSEPulse BiosciencesN/AN/AN/AN/ACurrent Analyst RatingsLatest KLDO, PLSE, BMK, and LXRX Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/3/2024LXRXLexicon PharmaceuticalsNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingHold4/30/2024LXRXLexicon PharmaceuticalsLeerink PartnrsSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform4/30/2024LXRXLexicon PharmaceuticalsSVB LeerinkSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageOutperform$5.004/23/2024LXRXLexicon PharmaceuticalsNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingHold4/11/2024LXRXLexicon PharmaceuticalsNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingHold(Data available from 6/4/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBMKMacDonald Mines ExplorationC$-74K-18.01C$0.00 per share13.00C($0.01) per share-3.50KLDOKaleido Biosciences$1.10M0.00N/AN/AN/ANaNLXRXLexicon Pharmaceuticals$1.20M359.10N/AN/A$0.38 per share4.61PLSEPulse Biosciences$700K1,072.06N/AN/A$0.81 per share16.78Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBMKMacDonald Mines Exploration-C$1.28M-C$0.02N/A∞N/AN/A-1,679.48%-174.36%9/3/2024 (Estimated)KLDOKaleido BiosciencesN/A-$2.24N/AN/AN/AN/AN/AN/AN/ALXRXLexicon Pharmaceuticals-$177.12M-$0.83N/AN/AN/A-8,311.12%-108.54%-61.97%8/1/2024 (Estimated)PLSEPulse Biosciences-$42.21M-$0.81N/A∞N/AN/A-86.15%-66.87%8/8/2024 (Estimated)Latest KLDO, PLSE, BMK, and LXRX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/7/2024Q1 2024PLSEPulse BiosciencesN/A-$0.17-$0.17-$0.16N/AN/A5/2/2024Q1 2024LXRXLexicon Pharmaceuticals-$0.18-$0.20-$0.02-$0.20$1.17 million$1.13 million3/28/2024Q4 2023PLSEPulse BiosciencesN/A-$0.21-$0.21-$0.20N/AN/A3/11/2024Q4 2023LXRXLexicon Pharmaceuticals-$0.23-$0.20+$0.03-$0.20$0.68 million$0.70 millionDividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBMKMacDonald Mines ExplorationN/AN/AN/AN/AN/AKLDOKaleido BiosciencesN/AN/AN/AN/AN/ALXRXLexicon PharmaceuticalsN/AN/AN/AN/AN/APLSEPulse BiosciencesN/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBMKMacDonald Mines Exploration3.840.180.27KLDOKaleido BiosciencesN/AN/AN/ALXRXLexicon Pharmaceuticals0.3515.5815.56PLSEPulse BiosciencesN/A7.067.06OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBMKMacDonald Mines Exploration0.79%KLDOKaleido Biosciences81.56%LXRXLexicon Pharmaceuticals74.70%PLSEPulse Biosciences76.95%Insider OwnershipCompanyInsider OwnershipBMKMacDonald Mines Exploration5.45%KLDOKaleido Biosciences9.00%LXRXLexicon Pharmaceuticals4.50%PLSEPulse Biosciences71.50%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableBMKMacDonald Mines Exploration238.08 millionN/ANot OptionableKLDOKaleido Biosciences7642.62 million38.79 millionNot OptionableLXRXLexicon Pharmaceuticals285246.24 million235.16 millionOptionablePLSEPulse Biosciences5655.22 million15.74 millionOptionableKLDO, PLSE, BMK, and LXRX HeadlinesRecent News About These CompaniesJune 3 at 3:52 PM | marketbeat.comPulse Biosciences (NASDAQ:PLSE) Trading Up 15.2%June 2 at 2:20 AM | americanbankingnews.comPulse Biosciences (NASDAQ:PLSE) Shares Gap Down to $12.05June 1 at 6:46 AM | americanbankingnews.comPulse Biosciences (NASDAQ:PLSE) Shares Down 5% May 29, 2024 | marketbeat.comPulse Biosciences (NASDAQ:PLSE) Hits New 1-Year High at $13.74May 28, 2024 | marketbeat.comPulse Biosciences (NASDAQ:PLSE) Trading Up 6.8%May 25, 2024 | finance.yahoo.comPresident & CEO of Pulse Biosciences Burke Barrett Buys More StockMay 25, 2024 | americanbankingnews.comInsider Buying: Pulse Biosciences, Inc. (NASDAQ:PLSE) CEO Acquires $85,600.00 in StockMay 24, 2024 | marketbeat.comPulse Biosciences (NASDAQ:PLSE) Shares Gap Down to $11.95May 23, 2024 | bovnews.comWhy Pulse Biosciences Inc (NASDAQ:PLSE) Stock went up 90.73% in Last Year?May 23, 2024 | insidertrades.comBurke Thomas Barrett Buys 10,000 Shares of Pulse Biosciences, Inc. (NASDAQ:PLSE) StockMay 22, 2024 | marketbeat.comInsider Buying: Pulse Biosciences, Inc. (NASDAQ:PLSE) CEO Buys 10,000 Shares of StockMay 22, 2024 | marketbeat.comPulse Biosciences (NASDAQ:PLSE) Sees Strong Trading VolumeMay 21, 2024 | marketbeat.comPulse Biosciences (NASDAQ:PLSE) Shares Up 8.2%May 20, 2024 | businesswire.comPulse Biosciences Announces Updated Timing of Rights Offering for Up to $60,000,000May 17, 2024 | medtechdive.comPulse Biosciences names new CEO, reassigns former leaderMay 16, 2024 | seekingalpha.comPulse Biosciences Stock: Signs Of Life Following Q1 UpdateMay 16, 2024 | finance.yahoo.comPulse Biosciences’ CellFX Nanosecond Pulsed Field Ablation (nsPFA™) Technology to be Featured in Several Presentations at The Heart Rhythm Society 2024 Annual MeetingMay 16, 2024 | businesswire.comPulse Biosciences' CellFX Nanosecond Pulsed Field Ablation (nsPFA™) Technology to be Featured in Several Presentations at The Heart Rhythm Society 2024 Annual MeetingMay 15, 2024 | massdevice.comPulse Biosciences names a new CEO with former boss moving to CCO roleMay 14, 2024 | finance.yahoo.comPulse Biosciences Enhances Executive Leadership TeamMay 13, 2024 | finance.yahoo.comPulse Biosciences, Inc. (NASDAQ:PLSE) Q1 2024 Earnings Call TranscriptNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCompany DescriptionsMacDonald Mines ExplorationCVE:BMKMacDonald Mines Exploration Ltd. engages in the acquisition, exploration, and development of mineral properties in Canada. The company primarily explores for gold, silver, copper, cobalt, and nickel deposits. It owns 100% interests in the Scadding-Powerline-Jovan project that covers an area of 19,455 hectares located in the southeast of the prolific Sudbury Mining Camp in Northern Ontario; and the Hembruff Copper Property, which consists of 30 mining claims that covers an area of 6.64 square kilometers situated in the Elliot Lake, Ontario. The company was formerly known as MacDonald Mines Limited. MacDonald Mines Exploration Ltd. was founded in 1935 and is based in Toronto, Canada.Kaleido BiosciencesNASDAQ:KLDOKaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company develops KB195 for the treatment of patients with urea cycle disorder; KB295 to treat ulcerative colitis; KB174 for the treatment of hepatic encephalopathy; and KB109 to treat COVID-19 disease. It also develops programs for the treatment of multi drug resistant infection, chronic kidney disease, atherosclerotic cardiovascular disease, cardio-metabolic syndrome, immuno-oncology, and inflammatory bowel diseases. The company has collaboration agreements with Institute Gustave Roussy, Washington University, and Janssen. Kaleido Biosciences, Inc. was incorporated in 2015 and is headquartered in Lexington, Massachusetts.Lexicon PharmaceuticalsNASDAQ:LXRXLexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; and LX9211, which is in Phase II clinical development for the treatment of neuropathic pain and LX2761, which is in Phase I clinical development for gastrointestinal tract. Lexicon Pharmaceuticals, Inc. has strategic collaboration and license agreements with Bristol-Myers Squibb Company and Genentech, Inc. The company was incorporated in 1995 and is headquartered in The Woodlands, Texas.Pulse BiosciencesNASDAQ:PLSEPulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
